Drug
Normal saline IV
Normal saline IV is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_1
4
67%
Ph phase_3
1
17%
Phase Distribution
4
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(3)
Detailed Status
Suspended3
Completed1
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 14 (66.7%)
Phase 31 (16.7%)
N/A1 (16.7%)
Trials by Status
suspended350%
completed117%
withdrawn117%
not_yet_recruiting117%
Recent Activity
0 active trials
Showing 5 of 6
completednot_applicable
Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation
NCT07348159
suspendedphase_1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders
NCT02946658
not_yet_recruitingphase_3
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
NCT06870370
suspendedphase_1
Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)
NCT03909750
suspendedphase_1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
NCT02952131
Clinical Trials (6)
Showing 6 of 6 trials
NCT07348159Not Applicable
Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation
NCT02946658Phase 1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders
NCT06870370Phase 3
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
NCT03909750Phase 1
Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)
NCT02952131Phase 1
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
NCT02987855Phase 1
Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6